MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
Rhea-AI Summary
MiMedx (Nasdaq: MDXG) will release its operating and financial results for the second quarter ended June 30, 2026 after market close on Wednesday, July 29, 2026, followed by a webcast and conference call at 4:30 p.m. Eastern Time. U.S. investors can dial 877-407-6184, international investors 201-389-0877, using Conference ID 13761338. A webcast replay will be available for about 30 days on the company’s website.
Positive
- None.
Negative
- None.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 22 | Q1 earnings date | Neutral | +4.5% | Scheduled first-quarter results call for April 29 after market close |
| Feb 17 | Q4 earnings date | Neutral | +0.8% | Scheduled fourth-quarter and full-year results call for February 25 |
| Oct 15 | Q3 earnings date | Neutral | +2.0% | Scheduled third-quarter results call for October 29 after market close |
| Jul 16 | Q2 earnings date | Neutral | +6.0% | Scheduled second-quarter 2025 results call for July 30 |
| Apr 16 | Q1 earnings date | Neutral | -2.5% | Scheduled first-quarter 2025 results call for April 30 |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Comparable earnings-date announcements showed mostly positive 24-hour reactions, including 4.53% and 6%, but also a -2.5% reaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30, 2026 after the market close on Wednesday, July 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13761338
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com